Sign Up Today and Learn More About Pheon Therapeutics Stock
Invest in or calculate the value of your shares in Pheon Therapeutics or other pre-IPO companies through EquityZen's platform.
Pheon Therapeutics Stock (PHET)
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
About Pheon Therapeutics Stock
Founded
2022
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Pheon Therapeutics Press Mentions
Stay in the know about the latest news on Pheon Therapeutics
Cytotoxic compounds
patents • Apr 02, 2025
mRNA Vaccine and Therapeutics Market Report 2025-2035: 430+ Patents Filed, Signaling Robust Growth in mRNA Intellectual Property
globenewswire • Apr 01, 2025
LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
prnewswire • Feb 18, 2025
LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
prnewswire • Feb 18, 2025
LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
pharmiweb • Feb 18, 2025
Pheon Therapeutics Management
Leadership team at Pheon Therapeutics
Vice President of R&D and Co-founder
Paul Jackson
Chief Scientific Officer
Leigh Zawel
Join now and verify your accreditation status to gain access to:
- Pheon Therapeutics Current Valuation
- Pheon Therapeutics Stock Price
- Pheon Therapeutics Management
- Available deals in Pheon Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pheon Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Pheon Therapeutics Revenue and Financials
- Pheon Therapeutics Highlights
- Pheon Therapeutics Business Model
- Pheon Therapeutics Risk Factors
- Pheon Therapeutics Research Report from SACRA Research
Trading Pheon Therapeutics Stock
How to invest in Pheon Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Pheon Therapeutics through EquityZen funds. These investments are made available by existing Pheon Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pheon Therapeutics stock?
Shareholders can sell their Pheon Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
